Improvement in hereditary hemorrhagic telangiectasia after treatment with the multi-kinase inhibitor Sunitinib
Crossref DOI link: https://doi.org/10.1007/s00277-016-2796-6
Published Online: 2016-08-15
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Droege, Freya
Thangavelu, Kruthika
Lang, Stephan
Geisthoff, Urban
License valid from 2016-08-15